Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Centessa Pharmaceuticals plc - American Depositary Shares (NQ:CNTA)

39.59 -0.01 (-0.03%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 533,372
Open 39.60
Bid (Size) 39.30 (100)
Ask (Size) 39.75 (100)
Prev. Close 39.60
Today's Range 39.56 - 39.62
52wk Range 10.95 - 40.26
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Centessa Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Centessa Pharmaceuticals plc - CNTA
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Forget Weight Loss Drugs: Here's An Even Better Reason to Invest in Eli Lilly ↗
Eli Lilly has more to offer than some investors realize. 
Via The Motley Fool

Performance

YTD
+67.1%
+67.1%
1 Month
-0.1%
-0.1%
3 Month
+60.2%
+60.2%
6 Month
+43.4%
+43.4%
1 Year
+214.5%
+214.5%

More News

Read More
News headline image
Is This $6.3 Billion Deal a Game Changer for Eli Lilly? ↗
Via The Motley Fool
News headline image
Looks Like M&A Week in 3 Different Sectors ↗
Via The Motley Fool
News headline image
Halper Sadeh LLC is Investigating Whether APLS, CNTA, KZR, EQH are Obtaining Fair Deals for their Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Shareholder Alert: The Ademi Firm investigates whether Centessa Pharmaceuticals plc is obtaining a Fair Price for Public Shareholders
From Ademi LLP
Via GlobeNewswire
News headline image
Lilly’s $7.8 Billion Centessa Bet: Inside the Race to Dominate the Sleep Market’s ‘Orexin Gold Rush’
Via MarketMinute
News headline image
Lilly’s $47.8 Billion Bet: Why the Contessa Acquisition Redefines the Future of Medicine
Via MarketMinute
Topics Artificial Intelligence
News headline image
Lilly's Next Empire: A $10 Billion Bet on AI and Neuroscience ↗
Via MarketBeat
Topics Artificial Intelligence
News headline image
Halper Sadeh LLC is Investigating Whether APLS, CNTA, EQH, VYNE are Obtaining Fair Deals for their Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
Wall Street Ends a Rough Quarter With Its Best Day, Iran Hope Ignites the Rally ↗
Via Chartmill
News headline image
Centessa Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Centessa Pharmaceuticals plc - CNTA
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Why Centessa Stock Soared Today ↗
Via The Motley Fool
News headline image
Halper Sadeh LLC is Investigating Whether APLS, CNTA, BIRD, WBD are Obtaining Fair Deals for their Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
Via Chartmill
Which stocks are experiencing notable movement on Tuesday? ↗
Via Chartmill
The market is filled with gapping stocks in Tuesday's session. ↗
Via Chartmill
News headline image
The Orexin Gold Rush: Deep Dive into Eli Lilly’s $7.8 Billion Acquisition of Centessa Pharmaceuticals
Via Finterra
Topics Economy Initial Public Offering Intellectual Property
News headline image
The $1 Trillion Goliath: Why Eli Lilly’s $6.3B Centessa Bet Defines the Future of Neuroscience
Via Finterra
Topics Economy Intellectual Property
Discover the top movers in Tuesday's pre-market session. ↗
Via Chartmill
News headline image
CNTA Stock Alert: Halper Sadeh LLC is Investigating Whether Centessa Pharmaceuticals plc is Obtaining a Fair Price for its Shareholders
From Halper Sadeh LLC
Via Business Wire
News headline image
Forget Centessa Pharmaceuticals: This Rare‑Disease Specialist Has a Superior Portfolio and Pipeline ↗
Via The Motley Fool
News headline image
Biotech Fund Dumps 1.85 Million Centessa Shares as Stock Jumps Over 50% ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
This Fund Just Disclosed a New $55 Million Bet on Centessa Amid 53% Stock Rally and CEO Transition ↗
Via The Motley Fool
News headline image
Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences
From Centessa Pharmaceuticals plc
Via GlobeNewswire

Frequently Asked Questions

Is Centessa Pharmaceuticals plc - American Depositary Shares publicly traded?
Yes, Centessa Pharmaceuticals plc - American Depositary Shares is publicly traded.
What exchange does Centessa Pharmaceuticals plc - American Depositary Shares trade on?
Centessa Pharmaceuticals plc - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Centessa Pharmaceuticals plc - American Depositary Shares?
The ticker symbol for Centessa Pharmaceuticals plc - American Depositary Shares is CNTA on the Nasdaq Stock Market
What is the current price of Centessa Pharmaceuticals plc - American Depositary Shares?
The current price of Centessa Pharmaceuticals plc - American Depositary Shares is 39.59
When was Centessa Pharmaceuticals plc - American Depositary Shares last traded?
The last trade of Centessa Pharmaceuticals plc - American Depositary Shares was at 05/15/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.